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The yeast rna mutations (rna2 through rnalOIII) are a set of temperature-sensitive mutations that result in
the accumulation of pre-mRNAs at the nonpermissive temperature. Most of the yeast RNA gene products are
involved in and essential for mRNA splicing in vitro, suggesting that they code for components of the splicing
machinery. We tested this proposal by using an in vitro-synthesized RNA11 protein to complement the
temperature-sensitive defect of the rnall extract. During the in vitro complementation, the input RNA11
protein was associated with the 40S spliceosome and a 30S complex, suggesting that the RNA11 protein is
indeed a component of the spliceosome. The formation of the RNAll-associated 30S complex did not require
any exogenous RNA substrate, suggesting that this 30S particle is likely to be a preassembled complex involved
in splicing. The RNAll-specific antibody inhibited the mRNA splicing in vitro, confirming the essential role of
the RNA11 protein in mRNA splicing. Finally, using the anti-RNA1 antibody, we localized the RNA11 protein
to the periphery of the yeast nucleus.
Through the development of in vitro splicing systems, a
two-step biochemical pathway for the removal of introns
from nuclear mRNA precursors (pre-mRNAs), referred to as
mRNA splicing, has been delineated (for a review, see
reference 42). This splicing reaction is done on a 40S to 60S
macromolecular complex, the spliceosome, on which the
reaction intermediates are confined (4, 15, 16). It is becoming
apparent that the complexity of such a large particle may
well be as great as that of the ribosomal subunits and that it
could contain a number of proteins and several RNAs.
To date, five major classes of small nuclear RNAs
(snRNAs; Ul, U2, U4 to U6) have been found to be involved
in mammalian mRNA splicing (for a recent review, see
reference 37). Of these, four (Ul, U2, U4, and U5) possess
a 5' trimethylguanosine (m3G) cap. All five snRNAs are
tightly associated with one or more proteins and function in
the form of small nuclear ribonucleoprotein particles
(snRNPs) (48, 56). The human autoimmune antiserum anti-
Sm has been used to precipitate these snRNAs and to
demonstrate that these snRNAs are required for mRNA
splicing (28, 43). The Sm antigens are a subset of snRNP
proteins found in all five of the snRNPs which function in
mRNA splicing (48). In yeasts, snRNAs also possess the 5'
m3G cap structure which renders them immunoprecipitable
by the anti-m3G antibody (reviewed in reference 18). Fur-
thermore, a subset of yeast snRNAs (e.g., snR7, snR14, and
snR20) contain potential Sm antigen-binding sites in their
single-stranded regions with a consensus sequence of
A(U3-)G (2, 19, 44, 49, 50, 60). Indeed, some of the human
anti-Sm antisera can precipitate these snRNAs from the
yeast extract (50, 60; S.-C. Cheng and J. Abelson, unpub-
lished data).
Recent analyses of the spliceosomal components per-
formed either by affinity purification of the spliceosome or
by native gel fractionation of the in vitro splicing systems
have revealed that several snRNPs (U2, U5, and U4 + U6
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for mammalian cell systems; snR6, snR7, snR14, and snR20
for the yeast system) reside on the spliceosomes (8, 17, 26,
27, 46, 47). In addition, the involvement of the heteroge-
neous nuclear RNP (hnRNP) complexes in mRNA splicing
and spliceosome formation has been implicated by inhibition
experiments with antibodies against the hnRNP core pro-
teins (9, 53). Spliceosome assembly follows a rather compli-
cated pathway, with several spliceosome intermediates ap-
pearing in sequence (8, 17, 27, 46, 47). The apparent
complexity of the spliceosome and the mRNA splicing
process demands a combined effort by both biochemical
fractionation and genetic analysis to enumerate all the com-
ponents involved in mRNA splicing and eventually to under-
stand their functions.
Taking advantage of the well-characterized genetic prop-
erties and the readily available mutants of the yeast Saccha-
romnces cerei'isiae, we have begun to analyze the mRNA-
splicing mechanism in detail. In particular, special attention
has been focused on a set of temperature-sensitive mutations
initially isolated by Hartwell (20) which form nine comple-
mentation groups denoted rna2 to rna10/11 (36). Although
originally thought to be defective in general RNA metabo-
lism, these *-na mutants turn out to be functionally impaired
in mRNA splicing at the nonpermissive temperature in a
very specific manner (51; reviewed in reference 36). By
developing an in vitro complementation assay, Lustig et al.
(36) have shown that many of the RNA genes are likely to
code for products directly involved in and essential for
mRNA splicing. In addition, most of the RNA gene products
are required for the formation of spliceosomes in vitro, with
an exception of the RNA2 gene product, which is a factor
extrinsic to the spliceosome (33). On the basis of these
studies, Lin et al. (33) proposed a three-step mechanism for
mRNA splicing and deduced multiple intrinsic and extrinsic
factors which are involved in the formation of the spliceo-
some.
We proceeded to examine the role of one of the RNA gene
products. the RNA11 protein, in mRNA splicing and its
relationship to the spliceosome. In this study, we first
demonstrated that the in vitro-synthesized RNA11 protein is
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capable of complementing the defects of heat-sensitive rnall
extracts. We then provided evidence that the RNA11 protein
is specifically associated with the 40S spliceosome and with
a 30S complex. Finally, using an anti-RNA11 antibody, we
showed that the RNA11 protein is essential for mRNA
splicing in vitro and is localized predominantly in the periph-
ery of the yeast nucleus.
MATERIALS AND METHODS
Yeast strains. The following yeast strains were used in this
study: the wild-type strain EJ101; rna2 strain SS304; rna5
strain RL173; rnall strains SPJ11.4 and AJL145.9d. The
genotypes of these strains have been described by Lin et al.
(34) and Lustig et al. (36).
Isolation of yeast splicing extracts. Extracts were prepared
from cells grown to the mid- to late log phase at 23°C in YPD
medium as described by Lustig et al. (36).
Preparation of splicing substrates. The wild-type and C259
actin transcripts used in this study have been described
previously (34, 58). Low-specific-activity transcripts and
antisense transcript were synthesized by the methods of
Cheng and Abelson (8).
Plasmid constructions and oligonucleotide-directed site-spe-
cific mutagenesis. Plasmid pAS1 containing the wild-type
RNAJJ gene in a 4.6-kilobase (kb) Hindlll fragment cloned
into pBR322 was kindly provided by R. Sternglanz of the
State University of New York at Stony Brook. Plasmid
M13mplO-RNAJJ was constructed by subcloning a 2.7-kb
BamHI-HindIII fragment encompassing the entire RNAJJ
gene into M13mp10. Two oligonucleotides with the following
sequences were synthesized and utilized to introduce a PstI
or EcoRI site just upstream of the RNAJJ gene: 5'-
CCCTTCTTACCTGCAGCTATTTGTGA-3' (26mer/PstI)
and 5'-TTTGAATTCTTGGATGCGTTA-3' (21mer/EcoRI).
Oligonucleotide mutagenesis was performed as described by
Newman et al. (40). After the mutagenesis, RNAli-con-
taining DNA fragments PstI-XbaI and EcoRI-HindIII were
transferred to pSP64 (39) and pKK223-3 (5) vectors, respec-
tively. Plasmids pSP64-RNAII and pKK223-3-RNAJJ were
then used to transform Escherichia coli strains MC1061 [F-
araD139 A(araABIOC-leu)7679 A(lac)x74 galU galK rpsL
hsr hsm+] and JM105 [A(lac-pro) thi strA endA sbcB15
hspR4 F' traD36 proAB /acIqZAM15), respectively.
In vitro transcription and in vitro translation. In vitro
transcription was performed essentially as described by
Melton et al. (39). The DNA templates used in the runoff
transcription reactions were generated by EcoRI or HaeIII
linearization of the pSP64-RNAII plasmid. Linear DNA
templates (50 ,ug/ml) were transcribed in 50 mM Tris (pH
7.5)-6 mM MgCl2-20 mM NaCI-1 mM spermidine-10 mM
dithiothreitol-RNasin (1 unit/,l)-0.5 mM each ribonucleo-
side triphosphate. Typically, 20 U of SP6 polymerase (Pro-
mega Biotec, Madison, Wis.) per ,ug of DNA template was
added for 2 to 3 h of synthesis at 37°C. After RNA synthesis,
the reactions were terminated by phenol-chloroform extrac-
tion and then precipitated directly by the addition of Tris (pH
8.0) to 0.5 M and 2 volumes of ethanol. The ethanol
precipitation was repeated three times to remove residual
contaminants. To monitor the RNA synthesis, we assembled
a small-scale reaction mixture supplemented with 5 ,uCi of
[a-32P]UTP (3,000 Ci/mmol; Amersham Corp., Arlington
Heights, Ill.), and the RNA molecules synthesized were
analyzed by 6% denaturing gel (19:1, acrylamide-bisacryl-
amide) electrophoresis and autoradiography.
To synthesize 35S-labeled proteins in vitro, we used the
rabbit reticulocyte lysate system (New England Nuclear
Corp., Boston, Mass.) and L-[35S]methionine (1,380 Ci/
mmol; Amersham). In vitro translation reactions were per-
formed following the instructions provided by New England
Nuclear Corp. In a typical 25-,u reaction mixture, 1.5 Rig of
RNA]] transcript or globin transcript (Bethesda Research
Laboratories, Inc., Gaithersburg, Md.) was incubated to-
gether with 10 ,l of rabbit reticulocyte lysate, 5.5 ,ul of
translation cocktail, 2 [LI of 1 M potassium acetate, 0.5 pul of
32.5 mM magnesium acetate, and 30 ,uCi of L-[35S]methio-
nine at 37°C for 1 h. Translated proteins were analyzed by
removing 1-pu samples from each reaction mixture and
fractionating them by sodium dodecyl sulfate-10% polyacryl-
amide gel electrophoresis (SDS-PAGE; 30). After electro-
phoresis, the gel was treated with 1 M sodium salicylate at
room temperature for 30 min and dried under a vacuum. The
dried gel was then subjected to autoradiography at -70°C
with an intensifying screen. The translated proteins in the
reaction mixture were used directly for in vitro complemen-
tation without further purification.
In vitro complementation and glycerol gradient analysis.
The in vitro complementation procedure was developed
based on that of Lustig et al. (36), in which heat inactivation
and splicing were done successively. For heat inactivation, 7
pul of yeast extract was mixed with 2.2 pI of cocktail 1 (15
mM MgCl2, 6.1 mM dithiothreitol, 16 units of RNasin) and 3
,ul of translation mix (or an equivalent amount of water) and
incubated at 32°C for 1 h. The reaction conditions were then
adjusted for splicing by adding 1.7 pA of cocktail 2 (300 mM
KPO4 [pH 7.0], 20 mM ATP, 20% polyethylene glycol 8000)
and 3.5 pA of 32P-labeled transcript (20,000 cpm/,lp). Splicing
was done at 15°C for 30 min. For minus ATP reactions, the
ATP in cocktail 2 was left out. For nonfunctional comple-
mentation, 7 pA of yeast extract was incubated with 2.2 plI of
cocktail 3 (11.4 mM MgCI2, 4.5 mM dithiothreitol, 12 units of
RNasin) at 32°C for 1 h. Subsequently, the translation mix,
cocktail 2, and 32P-labeled transcript were added for splicing
as described above for complementation reactions.
For gradient analysis, the complementation mixture was
diluted with 25 ,ul of gradient buffer without glycerol (50 mM
KCI, 2 mM MgCl2, 20 mM HEPES-K+ [potassium-N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid] [pH 7.4])
and layered on a 11 to 23% glycerol gradient (4.4 ml in a 2-in.
[5-cm] polyallomer centrifuge tube). The sedimentation was
performed at 23,700 x g (50,000 rpm) for 90 min at 2°C in a
Beckman SW55 rotor. Fractions were collected, and radio-
activities were determined by Cerenkov counting. Proteins
and nucleic acids in each fraction were then precipitated by
the addition of Triton X-100 to 0.1% and trichloroacetic acid
to 5% and chilled to -20°C overnight. The trichloroacetic
acid precipitates were collected by centrifugation, neutral-
ized by 2 ,1u of 2 M Tris (pH 9.0), and suspended in 15 pl of
gel loading buffer (60 mM Tris [pH 6.8], 2% SDS, 10%
glycerol, 40 mM P-mercaptoethanol, 0.02% bromophenol
blue). The samples were then boiled for 3 min and loaded on
an SDS-14% polyacrylamide gel (30) for electrophoresis. In
some cases, as noted in the text, the complementation
reaction mixture was treated with 2 pug of heparin for every
microliter of yeast extract used in the reaction before gradi-
ent analysis.
Overproduction of RNAll protein in E. coli. The RNA11
protein in an E. coli strain, JM105(pKK223-3-RNAll),
was overproduced by isopropyl- P - D-thiogalactopyranoside(IPTG) induction as described by Phizicky et al. (45). At the
end of IPTG induction, cells were harvested and lysed
directly in protein gel loading buffer containing SDS and
,B-mercaptoethanol. Typically, 80 pA of Tris-sucrose buffer
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(10 mM Tris [pH 7.4], 10% sucrose) was added for every
milliliter of culture volume per unit of optical density at 550
nm to suspend cells. The 5x gel loading buffer (0.3 M Tris
[pH 6.8], 10% SDS, 50%o glycerol, 2 M P-mercaptoethanol,
0.1% bromophenol blue) was then added to a final concen-
tration of 1 x. Samples (10 to 15 RI) were boiled before being
loaded on protein gels (30). A silver staining technique (62)
was used to visualize the proteins on the gel.
Preparation of the anti-RNAll antibody and immunoblot
analysis. The overproduced RNAll protein was first sepa-
rated from the bulk protein in the E. coli crude lysate by
ammonium sulfate precipitation (55% cut), loaded on a
heparin-agarose column, and eluted with a linear salt gradi-
ent (0.1 to 1.5 M NaCl). The peak fractions containing the
RNAll protein (between 0.2 and 0.6 M NaCl) were pooled
and concentrated by ammonium sulfate precipitation. Fur-
ther purification of the RNA11 protein was achieved by
SDS-14% PAGE (30), and gel slices which contained the
RNAll protein were then utilized to immunize New Zealand
White male rabbits as described by Phizicky et al. (45). The
antibody thus obtained was used in immunoblot analysis to
detect RNA11 protein in yeast extract or crude lysate
prepared from the RNAll-overproducing E. coli strain. The
procedures of electroblotting proteins onto nitrocellulose
filters and visualization of the RNA11 protein with anti-
RNA11 antibody, biotinylated secondary antibody, and
horseradish peroxidase have been described previously (10,
57).
Immunoprecipitation. Anti-m3G cap antibody and anti-Sm
(no. 58) human autoimmune antibody were generous gifts
from R. Luhrmann (Max-Planck-Institute, Berlin, Federal
Republic of Germany) and S. Hoch (Agouron Institute, La
Jolla, Calif.), respectively. The immunoprecipitation was
performed essentially as described by Wolin and Steiz (61).
Antibodies (from anti-Sm, anti-m3G, and anti-RNA11 anti-
sera or preimmune serum) were coupled to 2.5 mg of protein
A-Sepharose (Pharmacia, Inc., Piscataway, N.J.) in 0.5 ml
of NET-2 buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 0.05%
Nonidet P-40) at room temperature for 1 h. After NET-2
washes, the antibody-bound protein A-Sepharose was incu-
bated with either in vitro translation reaction mixtures or in
vitro complementation mixtures at 4°C for 1 h. The pellets
were then washed extensively with NET-2 buffer and ana-
lyzed by protein gel electrophoresis followed by autoradiog-
raphy. The 35S radioactivity was determined by incubating
the gel slices of interest in 10 ml of Econofluor containing 3%
Protosol (New England Nuclear Corp.) overnight at 37°C
and subsequent liquid scintillation counting.
Antibody inhibition of mRNA splicing in vitro. Wild-type
yeast extract (7 ,ul) was mixed with 7 ,ul of protein A-purified
antibody or with lesser amounts of antibody plus buffer D (20
mM HEPES (pH 7.9), 0.2 mM EDTA, 0.5 mM dithiothreitol,
50 mM NaCl, 20% glycerol) to a final volume of 7 RI and
incubated together for 30 min at 0°C. Then a solution
containing 32P-labeled RNA transcript (20,000 cpm/,ld) plus
all other components necessary for splicing (33) was added
to a final volume of 20 pul. The splicing reaction mixture was
incubated at 23°C for 30 min. Reactions were stopped and
analyzed by denaturing PAGE as previously described (33).
Immunofluorescence microscopy. Immunofluorescence mi-
croscopy was modified from the techniques for whole-mount
yeast cells developed by Kilmartin and co-workers (1, 25).
Because of the relatively low copy number of the RNA11
protein in the yeast cell, the cells were mounted for immu-
nofluorescence by the postfixation procedure detailed by
Clark and Abelson (10). The cells were converted into
spheroplasts by enzymatic digestion, washed, and then
mounted on the polylysine-coated slide and fixed with 3.7%
formaldehyde in 0.1 M potassium phosphate-citrate (pH
6.5)-1.2 M sorbitol for 10 min. After fixation, the mounted,
fixed spheroplasts were passed through -20°C methanol and
acetone for 6 min and 30 s, respectively, and then air dried
and stored at 6°C until used. These mounted spheroplasts
were then stained for immunofluorescence by the application
of 0.1 ml of a 1:500 dilution of the anti-RNA11 antiserum in
20 mM potassium phosphate (pH 7.0)-150 mM NaCl (phos-
phate-buffered saline)-0.1 mg of bovine serum albumin per
ml directly to the spheroplasts and incubated at 6°C for 16 to
18 h. For the double-label experiment, the anti-RNA11
antiserum was added directly to the human autoimmune
nucleolar (fibrillarin)-staining solution (ANA-N; Sigma
Chemical Co., St. Louis, Mo.) at a 1:500 dilution. This
solution was used in the same manner as described above.
After the primary incubation, the slides were washed with
buffer and incubated with a 1:100 dilution in phosphate-
buffered saline-bovine serum albumin of anti-rabbit immu-
noglobulin G (IgG)-fluorescein isothiocyanate (Sigma) or, for
the double-lable experiment, a 1:100 dilution in phosphate-
buffered saline-bovine serum albumin of both anti-rabbit
IgG-rhodamine isothiocyanate (Sigma) and anti-human IgG-
fluorescein isothiocyanate (Sigma) and incubated for 1 h at
room temperature. After this incubation, the mounted
spheroplasts were washed with buffer, 1 drop of 90% buff-
ered glycerol containing 20 mg of propyl gallate per ml was
applied, and a cover slip was attached. Slides were stored at
-20°C until viewing. Slides were viewed with a Zeiss
standard microscope with Nomarski interference optics and
fluorescein and rhodamine excitation wavelengths.
Immunoelectron microscopy. A modified procedure (de-
tailed in reference 10) of Byers and Goetsch (6) was used for
immunoelectron microscopy. On-section immune staining of
ultrathin sections was performed as described previously
(10, 12) except that the primary antibody used was the
anti-RNA11 IgG fraction at a concentration of 2.5 pug/ml.
Sequence analysis. Sequence data were assembled, trans-
lated, and analyzed with versions 4.2 and 4.5 of the Intelli-
genetics GENED, SEQ, and PEP programs of the BIONET
National Computer Resource for Molecular Biology. All
protein sequences used in homology searches were obtained
with the Intelligenetics QUEST, IFIND, and XFASTP pro-
grams with the National Institutes of Health sequence and
National Biomedical Research Foundation protein data
bases in BIONET.
RESULTS
Sequence of RNAII gene. The yeast RNAJJ gene was
initially cloned by genetic complementation (31, 55). While
characterizing the SIR2 gene, Shore et al. (52) independently
sequenced a 4.6-kb HindlIl fragment and identified an
unknown gene positioned 3' to the SIR2 gene. This unknown
gene was shown to be essential for cell growth (52) and was
later shown to be RNAJJ (R. Sternglanz, personal commu-
nication). The complete DNA sequence of the RNAJJ gene,
together with the SIR2 sequence, was deposited with the
EMBL sequence library (52). In Fig. 1, we summarize the
DNA sequence of the RNAJJ gene and its amino acid
sequence derived from the conceptual translation. The
RNAJJ gene (801 base pairs in length) codes for a protein of
266 amino acids with a calculated molecular weight of
29,924. The RNA]] protein, which has a net charge of +7
and contains a large number of charged residues, is a highly
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A (26mer/PstI) AGTG TTTATCGAcg TcCATTCTTC CC (21mer/EcoRI) A TTGCGTAGGT tctTAAGTT
-100 AAAAATCTGC TAAAGACGCA AGGCTCTCAC AAATAGCTTA ATGTAAGAAG GGCAGGTGGA ACAGCAAATT CAAATCATTT AACGCATCCA TACATTCAAA
1 ATG AAC TAT TTA GAA GGC GTT GGG TCA AAG AAA GGA GGT GGT GGT ATA GCC TCA GAA TCT CAG TTT AAC TTA CAA CGA AGG
Met Asn Tyr Leu Glu Gly Val Gly Ser Lys Lys Gly Gly Gly Gly Ile Ala Ser Glu Ser Gln Phe Asn Leu Gln Arg Arg
82 AAA GAA GTC GAA TCA TTA CTT AGT AAA GGC GAA AAT GTC CCG TAC ACT TTC CAA GAT GAA AAG GAC GAT CAA GTA AGG TCC
Lys Glu Val Glu Ser Leu Leu Ser Lys Gly Glu Asn Val Pro Tyr Thr Phe Gln Asp Glu Lys Asp Asp Gln Val Arg Ser
163 AAT CCG TAC ATT TAC AAG AAT CAT TCC GGT AAA CTG GTT TGT AAA CTA TGT AAT ACA ATG CAC ATG TCG TGG TCC AGC GTT
Asn Pro Tyr Ile Tyr Lys Asn His Ser Gly Lys Leu Val Cys Lys Leu Cys Asn Thr Met His Met Ser Trp Ser Ser Val
244 GAA AGG CAT TTG GGT GGT AAA AAA CAT GGT TTA AAT GTG TTA AGG CGT GGT ATC AGT ATA GAG AAA AGT TCT CTA GGG AGA
Glu Arg His Leu Gly Gly Lys Lys His Gly Leu Asn Val Leu Arg Arg Gly Ile Ser Ile Glu Lys Ser Ser Leu Gly Arg
HaelII
325 GAA GGC CAA ACA ACT CAT GAT TTC CGA CAA CAA CAA AAG ATA ATT GAA GCT AAG CAA TCT TTA AAG AAT AAC GGT ACG ATC
Glu Gly Gln Thr Thr His Asp Phe Arg Gln Gln Gln Lys Ile Ile Glu Ala Lys Gln Ser Leu Lys Asn Asn Gly Thr Ile
466 CCT GTT TGT AAA ATA GCT ACC GTG AAA AAC CCG AAG AAC GGT TCA GTA GGT TTG GCT ATC CAG GTA AAT TAT AGC AGT GAA
Pro Val Cys Lys Ile Ala Thr Val Lys Asn Pro Lys Asn Gly Ser Val Gly Leu Ala Ile Gln Val Asn Tyr Ser Ser Glu
487 GTC AAA GAA AAT AGT GTC GAT AGC GAT GAT AAG GCT AAA GTC CCT CCT CTC ATT AGG ATT GTA TCT GGT TTA GAG CTA TCA
Val Lys Glu Asn Ser Val Asp Ser Asp Asp Lys Ala Lys Val Pro Pro Leu Ile Arg Ile Val Ser Gly Leu Glu Leu Ser
568 GAT ACC AAA CAG AAG GGA AAA AAA TTT CTC GTT ATT GCG TAT GAA CCC TTT GAA AAT ATT GCT ATT GAG CTA CCT CCA AAC
Asp Thr Lys Gln Lys Gly Lys Lys Phe Leu Val Ile Ala Tyr Glu Pro Phe Glu Asn Ile Ala Ile Glu Leu Pro Pro Asn
649 GAA ATA TTA TTC AGC GAA AAC AAT GAC ATG GAC AAT AAT AAC GAT GGA GTA GAT GAA TTA AAT AAA AAG TGT ACA ITTI TGG
Glu Ile Leu Phe Ser Glu Asn Asn Asp Met Asp Asn Asn Asn Asp Gly Val Asp Glu Leu Asn Lys Lys Cys Thr Phe Trp
730 GAT GCT ATA TCA AAA CTT TAT TAC GTT CAA TTT TTC TTT AAA CAA GCC GAA CAA GAA CAA GCC GAT GTA TGA CAGTATTAT
Asp Ala Ile Ser Lys Leu Tyr Tyr Val Gln Phe Phe Phe Lys Gln Ala Glu Gln Glu Gln Ala Asp Val TRM
811 TTTTGGGTAA CGTTAATAAT CGGCATACAA AACTCTAACC AAATTGGATT ATATAATAGC TATTAAGGAA ACAATIGTCT TTACAAGAGT TTTTTTTACG
Xba I
911 AAATTTTCCC ATCCAATGTG CACTTATTCT CAGGGAGTAT AATAACCATA TTCCTCTAAA ATTATATTAC TGCTCAACTT CCATGCGCTT TTGCGATCTA
1011 GAGTATTTAT GTTACCATTT 1030
-1
81
162
243
324
405
486
567
648
729
810
910
1010
ZINC FINGERS
B
CONSENSUS:
FlY-X- K -X24-4gJ-X3- F- X5- L- X2 - X-x34- ---
RNA11 PROTEIN:
68 90
L-V- -K-L- -X3-H-X5-V-X2-H -X5- -------
hydrophilic protein as calculated by the method of Kyte and
Doolittle (29). There are four methionine residues in the
RNA11 protein. We compared the sequence of the RNA11
protein with the collection of protein sequences in the
BIONET data bases (GenBank) and failed to find any
significant homologies. However, a striking homology to the
so-called zinc fingers emerged after careful inspection of the
RNA11 protein sequence (Fig. 1B). The zinc finger is a
structural motif that binds Zn2+ tightly and occurs fre-
quently in the nucleic acid-binding proteins (reviewed in
reference 13). The presence of this motif suggests that
RNA11 is an RNA-binding protein.
Synthesis of RNA11 protein in vitro. To examine the role of
the RNA]] gene product during yeast mRNA splicing, we
first sought to synthesize 35S-labeled RNA11 protein in vitro.
We started out with a plasmid, pAS1 (provided by R.
Sternglanz), which contains the wild-type RNAJJ gene in a
4.6-kb HindIII fragment cloned into pBR322. A 2.7-kb
BamHI-HindIII fragment encompassing the entire RNAJJ
gene and its flanking sequences was then subcloned into
M13mplO for site-specific mutagenesis (Fig. 2). An oligonu-
cleotide, 26mer/PstI, which hybridizes to the 5'-flanking
sequence ofRNA] I at a position between -49 and -74 (Fig.
1), was utilized to introduce a PstI site 63 base pairs
FIG. 1. Sequence of the RNAJJ gene. (A) The RNAII gene
sequence is numbered starting from the first nucleotide of the
initiation codon (ATG). The termination codon (TGA) is underlined
and indicated as TRM. Upstream sequence is numbered starting as
-1 for the first nucleotide adjacent to the initiation codon.
26mer/PstI and 21mer/EcoRI are two oligonucleotides used for
site-specific mutagenesis. Lowercase characters denote the mis-
matches. Relevant restriction sites and the conceptually translated
amino acid sequence are also included. (B) The sequence of the
potential zinc finger motif in the RNA11 protein is aligned with the
zinc finger consensus of the C2H2 class (13). Highly conserved
cysteine and histidine residues are boxed and their positions in the
RNA11 proteins are indicated. X, Any amino acid.
upstream of the RNAJI initiation codon (Fig. 2). The PstI-
XbaI fragment containing the entire RNAII gene with a
single 5' initiation codon was then transferred to a pSP64
transcription vector to generate plasmid pSP64-RNAJI (Fig.
2). Transcription of the linearized pSP64-RNAIJ (by EcoRI
or HaeIII) plasmids in vitro with SP6 polymerase (39)
yielded both the full-length and the truncated RNAJJ tran-
scripts. These uncapped transcripts were then added to a
rabbit reticulocyte lysate system for in vitro translation. The
L-[35S]methionine-labeled RNA11 protein synthesized in vi-
tro had an apparent molecular weight of 32,000 (Fig. 3, lane
5). This molecular weight is in good agreement with the
calculated molecular weight of 30,000. In contrast, transla-
tion of the HaeIII-truncated RNAJJ transcript yielded a
truncated RNA11 protein with an approximate size of 15
kilodaltons (kDa) (Fig. 3, lane 4). The truncated RNA11
protein is expected to be 109 amino acids long.
In vitro complementation. The activity of the in vitro-
synthesized RNA11 protein in mRNA splicing was tested by
an in vitro complementation assay. Normally, the heat-
inactivated rna2, rna5, and rnall mutant extracts could
complement one another, regardless of whether the extracts
were mixed before or after heat inactivation (36). In con-
trast, when we added the RNA11 protein to the heat-
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FIG. 2. Strategy to express the RNAJI gene. The RNAJH gene,
presented as the large solid box, was originally cloned in the plasmid
pAS1 and transferred to the M13mplO vector for site-specific
mutagenesis. Subsequent to mutagenesis, the RNAJ) gene was
subcloned into appropriate vectors, pSP64 and pKK223-3, for in
vitro transcription and in vivo overexpression, respectively. The
arrow indicates the direction of RNAIJ gene transcription, and the
wavy lines represent the plasmid sequences. SP6 promoter is
portrayed as the small open box, and the tax promoter (ptac) is
shown as the small solid box. B, BamHI; E, EcoRI; Hae; HaeIII; H,
HindIII; P, PstI; X, Xbal.
inactivated rnall extract (now termed the nonfunctional
complementation assay), the splicing activity of the extract
was not restored. We reasoned that perhaps the RNA11
protein is an integral part of a temperature-sensitive complex
which, upon heat inactivation, might be permanently inacti-
vated. The addition of the free RNA11 protein after heat
inactivation would thus fail to regenerate the function of the
complex (see Discussion). We therefore tested an alternative
procedure (summarized in Fig. 4A) in which the heat inac-
tivation of the rnal l,extract was performed in the presence
of the RNAll translation mix, using conditions modified
from that of Lustig et al. (36). Subsequently, the 32P-labeled
pre-mRNA substrate (wild-type actin transcript produced in
vitro) was added, and conditions were adjusted for in vitro
splicing. The splicing products were then analyzed by PAGE
(Fig. 4B). Under the conditions used in this assay, the
full-length RNAll protein was able to restore the splicing
activity (lane 4) to a level close to that of the active rnall
extract (no heat inactivation; lane 1), while the mock trans-
lation mix (lane 2), the translated globin (lane 3), and the
translated truncated RNA11 protein (data not shown) all
failed to recover the splicing activity of the rnall extract lost
owing to heat inactivation.
Association of RNA11 protein with functional spliceosome.
It has been shown that a 40S complex (spliceosome) con-
taining pre-mRNA and intermediates of the splicing reaction
will form in active yeast extracts in the presence of a
functional pre-mRNA and ATP (4, 58). We wanted to
investigate the fate of the RNA11 protein during spliceosome
assembly. To this end, the distribution of the RNA11 protein
in the course of spliceosome formation was analyzed by
glycerol gradient sedimentation and SDS-PAGE (summa-
rized in Fig. 4A). Briefly, the in vitro complementation mix
was fractionated on a 50 mM KCI gradient (11 to 23%
glycerol), and the spliceosome assembly was monitored by
Cerenkov counting of the 32P radioactivity across the gradi-
ent. Subsequently, the "S-labeled RNA11 protein as well as
the 32P-labeled RNAs in each fraction were precipitated with
trichloroacetic acid, resolved by SDS-PAGE, and subjected
to autoradiography.
A small 40S peak at fraction 11 was detected together with
a larger 30S peak at fraction 15 (Fig. 5A, top). The result is
consistent with the profile previously described by Lin et al.
(33). This 40S complex contains pre-mRNA and intermedi-
ates of the splicing reaction, and its formation is dependent
on the presence of a functional pre-mRNA and ATP (data
not shown). Thus, the 40S complex is a functional spliceo-
some. On the other hand, the 30S complex contains exclu-
sively the uncleaved pre-mRNA, and its formation is ATP
independent and depends only on the presence of a func-
tional pre-mRNA (data not shown; see also reference 4). The
positions of the 30S and 40S peaks in the 50 mM KCI
gradient were different from the results previously obtained
by using 100 mM KCl gradients (4, 33, 58). It is known that
the sedimentation of the splicing complexes undergoes a
salt-dependent shift. At a higher salt concentration (e.g., 400
mM KCI), spliceosomes sediment more slowly than at a
lower salt concentration (e.g., 50 mM KCI) in the gradient (4,
16, 17; S. Goelz and J. Abelson, unpublished data).
We then analyzed both the 35S-labeled RNA11 protein and
32P-labeled RNA molecules simultaneously on an SDS-
polyacrylamide gel. Approximately 22 to 28% of the input
RNA11 protein cosedimented with the 40S complex, and 57
to 68% cosedimented with the 30S complex (Fig. 5A, bot-
tom). In control experiments utilizing either truncated
RNA11 protein or globin for in vitro complementation, the
40S spliceosome did not form, although the 30S complex still
appeared (Table 1). Neither the truncated RNA11 protein
M 1 2 3 4 5(kd)
69.0-
46.0-0
--Full-length RNA 1 1
30.0- -
14.3- w --Truncated RNA11
-Globin
FIG. 3. 'In vitro translation. The in vitro-synthesized RNAII
transcripts were translated in a rabbit reticulocyte lysate system.
Lanes: 1, "4C-labeled protein molecular size standards (M; in
kilodaltons [kd]); 2, mock translation (minus mRNA); 3, translation
of globin mRNA; 4, translation of the HaeIII-truncated RNAI1
transcript; 5, translation of the full-length RNAII transcript.
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FIG. 4. In vitro complementation assay. (A) Scheme for the in vitro complementation assay. TCA, Trichloroacetic acid; ppt.,
precipitation. (B) Results of the complementation assays. Lanes: 1, standard splicing reaction with the rnall extract; 2, complementation by
the mock translation mix; 3, complementation by the in vitro-translated globin product; 4, complementation by the full-length RNAll protein.
A, Heat inactivation; IVS*-E2, lariat intron-exon 2; IVS*, the excised lariat intron; El-E2, the spliced message; El, the excised exon 1.
nor the globin was associated with any complex. Instead,
both proteins remained on top of the gradients (Table 1), in
sharp contrast to the result with the full-length RNAll
protein.
Interestingly, the migration pattern of the RNA splicing
intermediates on the SDS-polyacrylamide gel resembled that
seen on a urea-polyacrylamide gel (cf. the control lane in
Fig. 6A and 4B). On SDS gels, the 32P-labeled exon 1 (the
fastest-migrating band in the 40S region) could be clearly
distinguished from the 35S-labeled RNA11 protein based on
the following criteria: (i) comigration of the fastest-migrating
band in the 40S region with exon 1 generated from a standard
splicing reaction (see control lane in Fig. 6A); (ii) the
correlation of the calculated molecular weight of exon 1 with
its distance of migration on the gel; (iii) the ability to detect
the radiation emitted from 32P-labeled exon 1 by autoradiog-
raphy through two layers of opaque X-ray films (35S radia-
tion cannot penetrate the films). The location of exon 1 in the
gradient is a clear marker for the spliceosome in these
experiments.
It is possible that the RNA11 protein is bound nonspeci-
fically to particles other than spliceosomes present in the 40S
region. This possibility was ruled out by experiments with
wild-type and rna2 extracts for in vitro complementation
(Table 1). Heat-inactivated rna2 extracts can support the
formation of a splicing-dependent 40S complex (termed
rna2A spliceosome) containing only the uncleaved pre-
mRNA (33). In contrast, in the wild-type extract, the 40S
spliceosome contains the uncleaved pre-mRNA as well as
the processed splicing intermediates (4). With these extracts,
the input RNAll protein did not sediment into the 40S
region, but remained predominantly on top of the gradients
(Fig. 5C; Table 1; see also below). Additionally, the results
of the complementation experiments with either antisense or
C259 mutant actin transcript also supported this argument
(Table 1; described below in detail).
To ascertain that the RNA11 protein does interact with the
40S spliceosome in a highly specific fashion, we treated the
complementation mix with heparin, a polyanion used to
eliminate nonspecific binding of proteins to RNAs (8, 17, 26),
before glycerol gradient centrifugation. This treatment re-
sulted in the slower migration of both the 40S and 30S
complexes on the gradient (Fig. 5B, top; see also reference
17), presumably owing to the removal of nonspecific, or
sometimes specific (e.g., binding of Ul snRNP to the spli-
ceosome; discussed in reference 3), binding components
from these two complexes. Despite the heparin treatment,
the RNA11 protein still remained bound to the 40S spliceo-
some (Fig. 5B, bottom). Centrifugation of the complemen-
tation mix in a high-salt (400 mM KCl) gradient gave a result
similar to that of the heparin treatment, i.e., the interaction
of the RNA11 protein with the now slower-migrating 40S
complex still remained (Table 1). Taken together, these data
indicate that the interaction between the RNA11 protein and
the 40S spliceosome is specific, not fortuitous.
To show that these results are not dependent on an
unknown strain effect, we repeated the in vitro complemen-
tation experiment described above (Fig. 5A) using an extract
prepared from strain AJL145.9d and obtained the identical
result (data not shown). Strain AJL145.9d is one of the
mutant spores produced on sporulation of the diploid
AJL145. This diploid was constructed by crossing the rnall-
carrying strain, SPJ11.4, with the wild-type strain, B346B
(36). The association of the RNA11 protein with the func-
tional 40S spliceosome is therefore not likely due to genetic
variations in the strain background.
Discovery of two distinct 30S complexes. Several splicing
complexes have been identified in the assembly pathway of
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FIG. 5. Distribution of the 35S-labeled RNA11 protein during in vitro complementation. Complementation mixtures were fractionated on
glycerol gradients, and components in each fraction were precipitated with trichloroacetic acid and analyzed by SDS-PAGE and
autoradiography. (A) Complementation with the rnall extract and the full-length RNA1l protein. (B) Same as panel A except treated with
heparin before gradient analysis. (C) Similar to panel A except the wild-type yeast extract was used. The top panels are the Cerenkov counting
profiles of the gradient fractions. The bottom panels are autoradiograms of the dried protein gels. Top and bottom. Top and bottom of the
gradient; IVS*-E2 and El, as described in the legend to Fig. 4B.
the yeast spliceosome. These complexes, resolved on either
glycerol gradients or native gels, were detected by using the
32P-labeled pre-mRNA (4, 8, 16, 26, 27, 46, 47, 58). A
different type of 30S complex can also be defined by the
presence of the 35S-labeled RNA11 protein in the particle.
As mentioned above, during in vitro complementation, the
majority (57 to 68%) of the input 35S-labeled RNA11 protein
was localized in the 30S region. Thus, we have, for conve-
nience, termed these two possible 30S complexes as the
[32P]30S and [35S]30S complexes.
To investigate the nature of the [35S]30S complex further,
we performed in vitro complementation assays using two
additional transcripts, the antisense actin transcript (8) and
the C259 mutant transcript (58). These transcripts do not
possess all the conserved sequences required for splicing
and therefore cannot be assembled into the 40S spliceosome
or the [32P]30S complex (S.-C. Cheng and J. Abelson,
unpublished data). Instead, they can only form a [32P]25S
complex (not precisely calibrated), presumably reflecting the
yeast hnRNP particle (S.-C. Cheng and J. Abelson, unpub-
lished data). As expected, the glycerol gradient profiles of
the experiments with these two transcripts indicated that a
[32P]25S complex (peaked at fraction 18) was formed (Fig.
6A, top), whereas the gel analyses revealed that a distinct
[35S]30S complex was also assembled (peak fractions 14 and
15; Fig. 6A, bottom). This [35S]30S complex contained most
of the input 35S-labeled RNA11 protein. Strikingly, the
association of the input RNA11 protein to this [35S]30S
complex was completely independent of the presence of the
RNA transcript, and heat inactivation of the rnall extract
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TABLE 1. Summary of the in vitro complementation experiments"
Cerenkov 32p
Expt Yeast extract [35S]protein [32Pltranscript ATP A counting [3LSprotenf
40S 30S 25S
1 SPJ11.4 Globin or truncated RNA11 WT + + - + - Top
2 SPJ11.4-AJL145.9d RNA11 WT + + + + - 40S + 30S
3 EJ101 (WT) RNA11 WT + + + + - Top
4 SS304 (rna2) RNA11 WT + + + + - Top
5 SPJ11.4* RNA11 WT + + - + - Top
6 SPJ11.4** RNA11 WT + + + + - 40S + 30S
7 SPJ11.4 RNA11 Antisense or C259 + + - - + 30S
8 SPJ11.4 RNA11 - - - - - - 30S
9 RL173 (rna5) RNA11 WT + + - + - Top
10 RL173-SS304-EJ101 RNA11 - - - - - - Top
a WT, Wild-type extract or wild-type actin transcript; A, heat inactivation; +, presence; -, absence; Top, top of the gradient; * nonfunctional complementation
reaction; **, sedimentation on a 400 mM KCI-glycerol gradient.
A
I
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FIG. 6. Association of the RNA11 protein t
(A) Complementation with the rnall extract
transcript. The dashed line in the top panel rept
the ATP-independent [32P]30S complex (see
tained from a separate experiment. Lane C, C
standard splicing reaction (bottom panel). IVS
described in the legend to Fig. 4B. (B) Incub;
protein with the rnall extract in the absei
transcript, and heat inactivation. The trailing o1
across the gradient, which can be eliminated b
(data not shown), may represent the nonspecif
RNA11 protein to various cellular components
was also unnecessary (Fig. 6B). Since the formation of
[32P]30S complex required the presence of a functional
pre-mRNA, the [35S]30S complex is clearly distinct from the
ATP-independent [32P]30S complex (Fig. 6A, top, dashed
line).
Association of RNA11 protein with 40S spliceosome and
[35S130S complex requires rnall extracts. Heat inactivation of
the rnall extract is required for the incorporation of the
RNA11 protein into the 40S spliceosome. Control experi-
ments were performed to test whether the RNA11 protein
could be incorporated when extracts from other rna mutants
were used. Standard in vitro complementation reactions
were done with the wild-type, rna2, and rna5 extracts. In
none of these cases was the RNA11 protein associated with
any complex (Table 1). This effect did not depend on the
presence or absence of the substrate RNA (Table 1). These
data suggest that the association of the input RNA11 protein
with both the 40S spliceosome and the [35S]30S complex is
32p.-pro-mRNA dependent on the rnall defect present in rnall extracts (see
Discussion).
Coprecipitation of RNAll protein with Sm and m3G epi-
.
-RNAII prtoin topes. Recent studies have demonstrated that at least three
snRNAs, snR7, snR14, and snR20, are associated with the
yeast spliceosome (8, 46, 47). These yeast snRNAs are also
immunoprecipitable by either the anti-m3G or anti-Sm anti-
body (49, 50). Thus, if the RNA11 protein is indeed associ-
ated with the spliceosome or any other complexes containing
the Sm or m3G epitope during the in vitro complementation
reaction, the RNA11 protein should also be immunoprecip-
itable by these two antibodies. This possibility was tested as
'358 -RNA Ii protei follows. A complementation reaction or a nonfunctionalasRNA I1tprotein
complementation reaction (described above) was carried out
and subjected to immunoprecipitation with either anti-m3G
or anti-Sm (no. 58) antibody. The immunoprecipitates were
then analyzed by SDS-PAGE and autoradiography.
For the complementation reaction, approximately 6.6 and
o the 30S complex. 13.8% of the input RNA11 protein could be precipitated by
t and the antisense anti-m3G and anti-Sm antibodies, respectively (Fig. 7, lanes
resents the profile of 4 and 5). Conversely, when the nonfunctional complemen-
text for details) ob- tation reaction was subjected to immunoprecipitation, only 2
ontrol RNAs from a to 3% of the input RNA11 protein was precipitated (Fig. 7,
atE2, IVS*, El, As lanes 1 and 2). Since in such a nonfunctional complementa-
nce of ATP, RNA tion reaction essentially all the input 3 S-labeled RNA11
f the RNA11 protein protein remained free on top of the glycerol gradient (Table
'y heparin treatment 1) and since the free RNA11 protein in the translation mix
ic association of the cannot be efficiently precipitated by either anti-m3G or
in the yeast extract. anti-Sm antibody (data not shown), this small amount (2 to
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FIG. 7. Coprecipitation of the RNA11 protein and snRNP epi-
topes by anti-Sm and anti-m,G antibodies. Nonfunctional comple-
mentation reactions (described in the text) were precipitated with
either anti-m,G (lane 1) or anti-Sm (no 58) (lane 2) antibodv. Lanes
4 and 5 are results from a typical in vitro complementation reaction
precipitated with either anti-m3G or anti-Sm antibody. respectively.
Lane 3 is the control input translated RNA11 protein without
immunoprecipitation. The immunoprecipitates were resolved on an
SDS-14% polyacrylamide gel. Quantitation of the radioactivity was
achieved by excising the band corresponding to the 35S-labeled
RNA11 protein from each lane followed by liquid scintillation
counting. [32P]-RNAs. RNA intermediates derived from splicing of
a low (1/30th of the standard)-specific-activity actin transcript.
3%) of precipitate is likely due to the background precipita-
tion by these two antibodies. When the precipitation results
for the complementation reaction were compared with those
for the nonfunctional complementation reaction, there was a
3.1- and 4.5-fold increase of the precipitated RNAll protein
by anti-m3G and anti-Sm, respectively. These data suggest
that during in vitro complementation, the RNAll protein is
associated with splicing complexes, to which the m3G and
Sm antigens are also associated. Note that the 32P-labeled
RNA transcript, although of a lower specific activity, could
also be detected as the coprecipitate (Fig. 7, lanes 4 and 5).
In experiments with a transcript with a higher specific
activity, coprecipitation of the RNA11 protein and the
splicing intermediates (e.g., exon 1) was even more signifi-
cant (data not shown). In summary, we showed that the
RNA11 protein can be coprecipitated with the spliceosome
or an snRNP by both anti-m G and anti-Sm antibodies.
suggesting that the RNA11 protein is associated with splicing
complexes during the in vitro complementation reaction.
Inhibition of mRNA splicing in vitro by anti-RNAI1 anti-
body. To learn more about the role of the RNA11 protein in
niRNA splicing, we raised antibodies against the RNA11
protein. Oligonucleotide mutagenesis was used to introduce
an EcoRI site upstream of the RNAII gene (Fig. 1 and 2).
The RNAJI gene was then inserted into the E. coli expres-
sion vector pKK223-3 (5) for overexpression (Fig. 2). In this
construct, the RNAJII gene is under the control of the hybrid
trp-lac (tac) promoter. E. coli cells containing this plasmid
(pKK223-3-RNAII) or the parent plasmid were grown and
induced with IPTG. Overproduction of the RNA11 protein
was easily detected by total protein analysis on an SDS-
polyacrylamide gel (Fig. 8A). A strong 32-kDa band corre-
sponding to the size of the RNA11 protein appeared only in
the pKK223-3-RNAI/-containing cells subjected to IPTG
induction (Fig. 8A, lane 4). We estimated that the overpro-
duced protein constitutes about 5% of the total proteins in
cells induced with IPTG. The overproduced protein was
purified by ammonium sulfate precipitation. heparin-agarose
chromatography. and preparative SDS-PAGE and used to
immunize rabbits.
The specific reactivity of the antibody that was raised was
ascertained by the following criteria. On immunoblots of the
yeast crude extract, the antibody recognized predominantly
a 32-kDa protein, close to the estimated molecular size of the
RNA11 protein (Fig. 8B, lane 2). Preimmune serum failed to
detect any protein in the same extract (lane 1). The antise-
rum was also able to detect a 32-kDa protein in the IPTG-
induced E. coli strain carrying the plasmid pKK223-3-
RNAII (lane 4). The 32-kDa protein was not visible in the
same E. coli strain without IPTG induction (Fig. 8A, lane 3),
nor was it detected by the antiserum (Fig. 8B, lane 3).
Finally, the antibody was able to efficiently immunoprecip-
itate the in vitro-translated RNA11 protein (Fig. 8C, lane 8)
as well as the truncated RNA11 protein (lane 6), but not the
in vitro-translated globin protein (lane 4). Preimmune serum
precipitated none of these in vitro-translated proteins (Fig.
8C, lanes 3, 5 and 7). Thus, we conclude that the antibody is
clearly specific for the RNA11 protein.
Antibody inhibition of mRNA splicing in vitro has been
used to demonstrate the critical role of snRNPs (28, 43) and
hnRNPs (9, 53) involved in mRNA splicing. We applied the
same approach to verify the requirement of the RNAI I gene
product for mRNA splicing.
Yeast splicing extract was preincubated with anti-RNA11,
anti-m3G, or preimmune antibody at 0°C; then splicing was
allowed to take place at 23°C (Fig. 9). Addition of the
preimmune antibody had no effect on splicing (lanes 1 to 3).
The anti-m3G antibody completely blocked all splicing reac-
tions (lanes 7 and 8), even when as little as 0.5 ,ul was added.
This result confirms the essential role of the capped snRNAs
in mRNA splicing (7, 28). The addition of 3 to 7 ,ul of the
anti-RNAll antibody significantly inhibited splicing, al-
though it did not block splicing completely (lanes 4 to 6).
Quantitation of splicing by excision of RNA bands from the
polyacrylamide gel and Cerenkov counting revealed that
only 10 to 20% residual splicing remained (data not shown).
Both steps of splicing were equally inhibited. Larger vol-
umes of antibody could not be accommodated because the
dilution inhibits splicing. Addition of smaller volumes of
anti-RNA11 antibody caused less inhibition (data not
shown). Presumably, the inability of the anti-RNA11 anti-
body to block splicing completely. in contrast to the results
of the anti-m,G antibody, indicates a lower titer or affinity of
the antibody. Preincubation of the splicing extract with the
antibody was required to achieve inhibition. Addition of the
antibody at the onset of the splicing reaction did not inhibit
splicing to any significant extent (data not shown), a finding
in line with the work of others (9, 43, 53). Our results show
that the binding of the RNA11-specific antibody to the
RNA11 protein in splicing extracts prevents mRNA splicing,
either by removing RNA11 protein or by altering its intrinsic
activity. These results support the previous genetic obser-
vations (36) that the RNAII gene product is essential for
mRNA splicing.
Location of RNAII protein in periphery of the yeast nu-
cleus. Since, as we just showed, the RNA11 protein is
associated with the spliceosome, we wanted to use the
anti-RNA11 antibody in immunocytological analysis to de-
termine the cellular location of the RNAll protein and thus
the site of mRNA splicing. Because of the presumed low
copy number of the RNAll protein, the accessibility of the
protein in the cells had to be optimized for the immunoflu-
orescence procedure. The cells used for immunofluores-
cence were first converted to spheroplasts, mounted on glass
slides, and then fixed with 3.7% formaldehyde in buffer (10).
The indirect immunofluorescence results with the wild-
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FIG. 8. Overproduction of the RNA11 protein and specific reactivity of the anti-RNA11 antibody. (A) Overproduction of the RNA11
protein in E. coli JM105. Total protein from cells harboring either the plasmid pKK223-3-RNAJ (lane 3, no IPTIG induction; lane 4, with IPTG
induction) or the parent plasmid (pKK223-3) (lane 2) or from the plasmid-free JM105 cells (lane 1) was resolved by SDS-12% PAGE and
visualized by the silver staining technique. The presence or absence of the IPTG induction and of the RNAHI gene in the cells is indicated
by + or -, respectively. M, Protein molecular size standards (kilodaltons [kd]). (B) Immunoblot analyses. Lanes 1 and 2, EJ101 yeast extract
containing 50 ,ug of proteins was fractionated on an SDS-12% polyacrylamide gel, transferred to nitrocellulose filters, and hybnrdized with the
preimmune (lane 1) or the anti-RNAll immune (lane 2) serum at a dilution of 1:500. Lanes 3 and 4, E. coli cells harboring plasmid
pKK223-3-RNAJ were grown with (lane 4) or without (lane 3) IPTG induction and lysed in the SDS-gel loading buffer, and 10 R1 of the lysate
was then analyzed on an immunoblot. The dilution of the anti-RNAll antiserum was 1:1,500. Minor bands in lane 4 may represent the
breakdown products of the overproduced RNAll protein. M, Prestained protein molecular size standards. (C) Immunoprecipitation of the
in vitro-translated proteins. A 3-,ul sample of the preimmune serum (lanes 3, 5, and 7) or the anti-RNAll antiserum (lanes 4, 6, and 8) was
used for precipitation. Lane 1, Input translated RNAll protein; lane 2, "4C-labeled protein molecular size standards; lanes 3 and 4,
precipitation of the translated globin; lanes 5 and 6, precipitation of the translated truncated RNAll protein; lanes 7 and 8, precipitation of
the translated full-length RNAll protein.
type yeast cells stained with an anti-RNA11 antiserum are
shown in Fig. 10A. The anti-RNA11 antibody stained the
nucleus but not the entire nucleus, as analyzed by Nomarski
optics (see arrowheads in Fig. lOB). A preabsorption exper-
iment (Fig. 10C) was done to show that this nuclear signal is
due to the RNA11 antigen. In this experiment, 2 to 5 M
equivalents of partially purified RNA11 protein were added
to the anti-RNA11 antiserum dilution before the immunoflu-
orescence staining. This treatment of the antiserum totally
eliminated the nuclear signal (Fig. 10C). Thus, these data
strongly suggest that the RNA11 protein is localized in a
region of the yeast nucleus.
Closer examination of the nuclear location of the RNA11
protein revealed that the nuclear area stained by the anti-
RNA11 antiserum, determined from 68 cells, consisted of
55% of the yeast nucleus as seen by Nomarski optics. This
regional location for the RNA11 protein is most likely due to
the exclusion of the RNA11 protein from the nucleolus. We
tested this proposal by performing double-label immunoflu-
orescence staining experiments using the rabbit anti-RNA11
antiserum and a human autoimmune antiserum to a nucleolar
protein. This human autoimmune antiserum, referred to as
fibrillarin (41), reacts with the yeast nucleolus (M. W. Clark
and J. Abelson, unpublished data). The RNA11 protein
appeared to be external to the nucleolus and occupied most
of the nuclear area seen by Nomarski optics (Fig. 11C,
arrowheads). Conversely, the fibrillarin antibody (Fig. llB)
stained only a small portion of the nucleus with a thin
crescent pattern. The yeast nucleolus, unlike the nucleolus
of higher organisms, has been described as a crescent
attached to the nuclear envelope (24, 53). The localization
for the RNA11 protein is not totally an unexpected result,
since mRNA-splicing components are likely not to be re-
quired for rRNA processing.
An even more specific compartmentalization of the
RNA11 protein and mRNA splicing was observed when the
RNA11 protein localization was examined at a higher reso-
lution by immunoelectron microscopy. Ultrathin sections of
the Epon-embedded yeast cells were stained with the anti-
RNA11 IgG or the preimmune IgG by the on-section staining
technique (12). The nuclear staining pattern caused by the
anti-RNA11 IgG, as visualized with a goat anti-rabbit IgG-
colloidal gold conjugate, is shown in Fig. 12 A through F.
Similar to the immunofluorescence mapping, the RNA11
protein, detected as 20-nm gold particles, can only be seen in
a part of the yeast nucleus. To obtain quantitative evidence
of the RNA11 localization, we collected data from many cell
sections using the inner membrane of the nuclear envelope
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FIG. 9. Inhibition ofmRNA splicing by specific antibodies. After
the wild-type extract was treated with preimmune serum (7, 5, and
3 RI1; lanes 1 to 3), anti-RNA11 (7, 5, and 3 p.; lanes 4 to 6), or
anti-m3G antibody (2 and 1 pul; lanes 7 and 8), a standard mRNA
splicing reaction was assembled for each treated extract to assess
the degree of antibody inhibition. IVS*-E2, IVS*, E1-E2, and El,
As described in the legend to Fig. 4B.
as a point of reference and measuring the shortest distance
from that point to the gold particles, both in and out of the
nucleus. We then plotted these distances for anti-RNA11
IgG and preimmune IgG on the histograms shown in Fig.
12G and H, respectively. By comparing these two histo-
grams, one can see definite staining for RNA11 in the
nucleoplasm within about 300 nm from the nuclear envelope.
This staining peaks around 75 to 100 nm from the nuclear
envelope. The cytoplasmic staining with the anti-RNA11
antibody is probably due to the nonspecific background
staining (cf. Fig. 12G and H; Table 2). We therefore con-
clude that the RNA11 protein is localized predominantly in
the nucleoplasm at the periphery (within 300 nm) of the
nuclear envelope.
DISCUSSION
In yeasts, most of the RNA gene products are likely to be
involved in mRNA splicing in vitro (36). Their roles, how-
ever, may vary. For instance, the RNA2 gene product is a
factor extrinsic to the spliceosome required for completion
of mRNA splicing, but not for the formation of the spliceo-
some itself (33). It is likely that many of the RNA gene
products are integral components of the spliceosome. Our
goal was to search for such a spliceosome-specific marker,
which may greatly facilitate research on the spliceosome in
the future. In this report, we demonstrated, using an in vitro
complementation assay, that the in vitro-synthesized RNAJ l
gene product is active in complementing the genetic defect of
the rnall extract. Moreover, we found that during the in
vitro complementation reaction, the RNA11 protein is asso-
ciated with both the 40S spliceosome and a 30S complex.
FIG. 10. Immunofluorescence of RNA11 protein and preabsorp-
tion control. (A) Formaldehyde (3.7%)-fixed spheroplasts of EJ101
cells stained with rabbit anti-RNA11 antiserum and goat anti-rabbit
IgG-fluorescein isothiocyanate conjugate showing fluorescence in a
region of the nucleus. (B) The same field as in panel A. The dark,
convex bulge in the cell (arrowheads) is the yeast nucleus (see also
reference 9). (C) Formaldehyde (3.7%)-fixed spheroplasts of EJ101
cells stained as in panel A except that 2 to 5 M equivalents of the
partially purified RNA11 protein were added to the anti-RNA11
antiserum dilution. This treatment eliminates the antiserum reactiv-
ity to the RNA11 protein in the cell and removes the nuclear
fluorescence. (D) Same field as in panel C. Panels A and C are
viewed under fluorescein excitation wavelengths. Panels B and D
are viewed by Nomarski interference optics. Bar, 5 p.m.
Using the anti-RNA11 antibody, we showed that the RNA11
protein is required forAmRNA splicing and that the RNA11
protein is localized predominantly in the periphery of the
yeast nucleus.
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FIG. 11. Double-label immunofluorescence showing the nuclear
location of the RNA111 protein relative to fibrillarin, a nucleolar
protein. Formaldehyde (3.7%)-fixed spheroplasts were stained with
rabbit anti-RNA11 antiserum, human anti-fibrillarin autoimmune
serum (Sigma) and, as secondary antibodies, anti-rabbit IgG-rho-
damine isothiocyanate conjugate and anti-human IgG-fluorescein
isothiocyanate conjugate. (A) Cells viewed by rhodamine excitation
wavelengths. (B) Cells viewed by fluorescein excitation wave-
lengths. (C) Cells viewed by Nomarski interference optics. Arrow-
heads point to the region of the cell nucleus which contains the
antifibrillarin stain, i.e., the nucleolus. Bar, 5 p.m.
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FIG. 12. Immunoelectron microscopic localization of the RNA11 protein. (A-F) Ultrathin Epon sections of EJ101 cells showing the
nucleus. * in panel D indicates the lumen between the inner and outer membrane of the nuclear envelope slightly swollen by the fixation and
embedding procedure. Sections are stained with rabbit anti-RNA11 IgG, and this antibody is visualized with goat anti-rabbit ItG-20-nm
colloidal gold complex. Colloidal gold particles can be seen in a section of the nucleoplasm. Nuc, Nucleus. Bar, 0.5 ,um. (G) Histogram of
combined data from 146 cell sections stained as described for panels A through F. (H) Histogram of combined data from 155 cell sections
stained as described for panels A through F except that the primary antibody was the RNA11 preimmune IgG.
RNAII gene product and in vitro complementation. Succes-
sive transcription and translation of the RNAJ I gene in vitro
yielded a 32-kDa RNA11 protein (Fig. 3). Under the condi-
tions used, approximately 2.6 ng (87.5 fmol) of the RNAll
protein was synthesized per jig of the input RNAJI tran-
script. Specific antibody raised against the RNA11 protein
recognized predominantly a 32-kDa protein in the yeast
extract and the E. coli RNA11-overproducer lysate (Fig.
8B), indicating the fidelity of the in vitro translation.
The in vitro-synthesized RNA11 protein could comple-
ment the defect of the rnall extract (Fig. 4B). The in
vitro-translated globin and truncated RNA11 protein failed
to do so (Fig. 4B), demonstrating a specific requirement of
the RNA11 protein for complementation. The failure of the
truncated RNA11 protein to complement the lost splicing
activity suggests that the C-terminal half is important for a
fully functional RNA11 protein. It is interesting that the
complementation assay worked only when heat inactivation
TABLE 2. RNA11 immunoelectron microscope data quantitation
Area of cell Anti-RNA11 golds (%) Preimmune golds (%)
Nucleoplasm 183 (44) 23 (8)
Nuclear envelope 18 (4) 9 (3)
Cytoplasm 217 (52) 260 (89)
was performed in the presence of the RNA11 protein. The
discovery that the input RNA11 protein is associated with a
30S complex in the absence of the RNA substrate (Fig. 6;
Table 1) suggests a possible explanation. In the absence of
the wild-type RNA11 protein, heat inactivation may irre-
versibly destroy this endogenous 30S complex containing
the mutant RNA11 protein. In the presence of the wild-type
RNA11 protein, exchange between the mutant RNA11 pro-
tein and its wild-type counterpart could perhaps stabilize or
preserve the function of this complex. This proposal can be
supported by previous data (36, 37), which have demon-
strated a free exchange of the components involved in
spliceosome assembly. Wild-type RNA11 protein in the 30S
complex may not exchange with the exogenously added
wild-type RNA11 protein owing to the intrinsic stability of
the 30S complex. Indeed, in experiments with wild-type,
rna2, or rnaS extract, the input RNA11 protein did not
associate with any complex (Table 1).
Association of RNAll protein with 40S spliceosome. Two
lines of evidence suggest that the RNA11 protein is associ-
ated with the 40S spliceosome during in vitro complementa-
tion. First, upon glycerol gradient sedimentation, a signifi-
cant fraction of the input RNA11 protein comigrated with the
40S spliceosome (Fig. 5A) and remained so despite stringent
treatments with either heparin or high salt (Fig. SB; Table 1).
Second, anti-Sm and anti-m3G antibodies were able to
MOL. CELL. BIOL.
RNAll PROTEIN AND YEAST SPLICEOSOME 2391
coprecipitate the RNA11 protein and the RNA splicing
intermediates (Fig. 7). Recent immunoelectron microscopy
studies with anti-RNA11 IgG to label the purified spliceo-
somes also suggest that RNA11 protein is present in the
spliceosome (M. W. Clark et al., manuscript in preparation).
One can calculate the stoichiometry between the RNA11
protein and the spliceosome by assuming that there is one
exon 1 per spliceosome. The calculated result is 0.3 to 0.4
(RNA11 protein/exon 1), but the interpretation of this num-
ber is complicated by the finding that several spliceosome
intermediates are involved in the mRNA splicing pathway
(8, 27, 47). Thus, the spliceosome as originally defined (4) is
in fact a mixture of all these complexes, so there are likely to
be 40S complexes which do not contain RNA splicing
intermediates.
Nature of 30S complexes. During the in vitro complemen-
tation reaction, the RNA11 protein was also associated with
a 30S particle (Fig. 5A and B). Two 30S complexes can be
separately defined, namely, the [32P]30S and the [35S]30S
complexes. The ATP-independent [35S]30S complex was
detected only when the rnall extract was used for the
complementation assay, and its formation was independent
of the exogenously added RNA substrate (Fig. 6B; Table 1).
This is in contrast to the ATP-independent [32P]30S com-
plex, which forms in active yeast extracts and requires the
presence of a functional pre-mRNA (4, 58). It is interesting
to note that Frendewey and Keller (15) have reported a 35S
preslicing complex, likely to be the [32P]30S counterpart in
the HeLa cell system, formed in the absence of ATP. The
[35S]30S complex is also distinct from the 25S complex,
which formed on RNA substrates lacking all the required
splicing signals (Fig. 6A). The 25S complex may represent
the yeast hnRNP particles, for it forms on many RNAs
lacking the splicing signals (S.-C. Cheng and J. Abelson,
unpublished data).
What is the nature of the [35S]30S complex? One attractive
possibility is that it represents an snRNP or a complex of
several snRNPs in the yeast extract. Konarska and Sharp
(27) have recently reported that a 25S multi-snRNP particle
containing U4/6 and U5 snRNPs is preformed in the HeLa
nuclear extract and proposed that this multi-snRNP complex
interacts with the U2-bound pre-mRNA to form the mature
spliceosome. Interestingly, Cheng and Abelson (8) have also
identified such a multi-snRNP in the yeast extract containing
snRNAs (snR14, snR6, and snR7) homologous to the mam-
malian U4, U6, and U5, respectively. Unfortunately, the
sedimentation coefficient of the yeast multi-snRNP is cur-
rently unknown. Most recently, Lossky et al. (35) have
demonstrated, using anti-RNA8 antibodies, that the RNA8
protein is in stable association with snR7 and undergoes an
additional ATP-dependent association with snR14 and snR6.
These data are in good agreement with the observations
described above, raising the possibility that the RNA11
protein is also an snRNP protein. Our preliminary studies
with the RNA11-specific antibody failed to detect any
snRNA specifically bound to the RNA11 protein. Perhaps
RNAll protein is not easily accessible to the antibody, as
suggested by our antibody inhibition experiments (Fig. 9), or
perhaps it is simply loosely bound to an snRNP. It is also
possible that the [35S]30S complex is a large snRNP consist-
ing of a single snRNA of extraordinary length, such as snR20
(1,175 nucleotides) or snR19 (569 nucleotides). Future work
is required to explore all these possibilities. The relationship
between [35S]30S and [32P]30S complexes, if any, also re-
mains an open question.
Inhibition of splicing by anti-RNAll antibody. A functional
RNAII gene is essential for mRNA splicing in vitro (36) and
for cellular viability in vivo (52). The former was confirmed
by the antibody inhibition experiment, in which the splicing
reaction was greatly diminished by preincubating the wild-
type yeast extract with the anti-RNA11 antibody (Fig. 9).
Unlike the complete inhibition of the splicing reaction by
anti-m3G antibody, anti-RNA11 antibody only partially di-
minished the splicing activity. This may be attributed to a
lower titer or affinity of the anti-RNA11 antibody compared
with that of the anti-m3G antibody, or it may be due to only
the partial accessibility of the RNA11 antigen in the yeast
extract. Anti-RNA11 antibody inhibited both steps of splic-
ing equally well, indicating that it either acts at the step
before the first cleavage reaction, as previously suggested by
Lin et al. (33), or interferes equally at both cleavage and
ligation reactions.
Subnuclear location of RNAll protein. A previous immu-
nofluorescence study has placed the overproduced RNA2
and RNA3 proteins in the yeast nucleus (32). Our immuno-
fluorescence-determined nuclear location for wild-type lev-
els of the RNA11 protein agrees with this study. Our studies
also demonstrated that at least one of the RNA gene prod-
ucts (i.e., the RNA11 protein) does not reside in the yeast
nucleolus. About one-third of the yeast nuclear volume is
directed toward rRNA synthesis and preribosome assembly
(54). The mRNA-splicing components appear not to have
access to this area of the nucleus. This compartmentalization
of function in the yeast nucleus seems to extend to even finer
detail.
We showed that the RNA11 protein is located in the
periphery of the nucleus, within a region 250 to 300 nm in
from the nuclear envelope. The peak of the RNA11 protein
location is about 75 to 100 nm in from the nuclear envelope.
Other mRNA-splicing components show this same nuclear
location. For instance, the anti-Sm (no. 58) antiserum was
used in immunoelectron microscopy to localize the yeast Sm
antigens, and its localization pattern appears to be similar to
that of the RNA11 protein (M. W. Clark and J. Abelson,
unpublished data). The compartmentalization of mRNA-
splicing components that we observed in yeast cells has also
been found in higher eucaryotes. Fakan and co-workers (14)
have examined the distribution of hnRNPs and snRNPs by
immunoelectron microscopy. By immunofluorescence mi-
croscopy, hnRNPs and snRNPs show both a distinct punc-
tate and a diffuse nuclear staining pattern; in their study,
Fakan and co-workers (14) present electron micrographs
which reveal that the staining for both of these particles
predominates in the periphery of the rat liver nucleus. These
data, taken together, indicate that the mRNA-splicing com-
ponents are not only sequestered into a macromolecular
complex, the spliceosome, they are also located in a specific
nuclear subcompartment, the nuclear periphery. One expla-
nation for this subnuclear localization of mRNA splicing is
that mRNA transcription is also occurring in the nuclear
periphery. The mRNA-splicing components thus become
localized by binding to the nascent precursor mRNAs.
Recent experiments to map the site of mRNA transcrip-
tion place transcription components in the nuclear periph-
ery. The yeast heat shock transcription factor, which binds
to the promoter regions of the yeast heat shock genes (59),
has been mapped by immunofluorescence and immunoelec-
tron microscopy to the same sites as the RNA11 and Sm
proteins (M. W. Clark and J. Abelson, unpublished data).
Also by immunoelectron microscopy, Clark and Hamkalo
(11) have localized RNA polymerase II in the periphery of
the mouse cell nucleus. This phenomenon of compartmen-
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talization of nuclear mRNA function seems to extend from
yeasts to mammals and indicates its importance in proper
nuclear function. The existence of a specific mechanism
responsible for this nuclear organization may also be implied
from these data. The tissue-specific ordering of the chromo-
somes reported in Drosophila larva nuclei (22, 23), Purkinje
cell nuclei (38), and plant cell nuclei (21) might account for
the observed compartmentalization of RNA-processing
functions. In such a model of nuclear organization, the
chromosomes would be arranged so that the sites of tran-
scription are at the nuclear periphery where the RNA-
processing enzymes are concentrated. Experiments to inves-
tigate the placement of the chromosomes in the yeast
interphase nucleus are currently under way (M. W. Clark
and J. Abelson, unpublished data).
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